Skip to main content

Inflamase Forte Side Effects

Generic name: prednisolone ophthalmic

Medically reviewed by Last updated on Apr 11, 2021.

Note: This document contains side effect information about prednisolone ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Inflamase Forte.

For the Consumer

Applies to prednisolone ophthalmic: ophthalmic solution, ophthalmic suspension

Side effects requiring immediate medical attention

Along with its needed effects, prednisolone ophthalmic (the active ingredient contained in Inflamase Forte) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking prednisolone ophthalmic:

Incidence not known

  • Blindness
  • blurred vision
  • burning, dry, itching eyes
  • change in vision
  • decreased vision
  • difficulty in focusing
  • drooping of the upper eyelids
  • eye discharge, excessive tearing
  • feeling of having something in the eye
  • redness, irritation, pain, swelling of the eye, eyelid, or inner lining of the eyelid
  • sensitivity of the eye to light
  • slow wound healing

Side effects not requiring immediate medical attention

Some side effects of prednisolone ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

  • Change in taste
  • headache
  • loss of taste

For Healthcare Professionals

Applies to prednisolone ophthalmic: ophthalmic solution, ophthalmic suspension


While the exact frequency of the reported side effects is unknown, the manufacturer reports the following in decreasing order of frequency: elevation of intraocular pressure with possible development of glaucoma and infrequent optic nerve damage, posterior subcapsular cataract formation, and delayed wound healing.[Ref]


Rare (less than 0.1%): Filtering bleb

Frequency not reported: Intraocular pressure increased, glaucoma, optic nerve damage, posterior subcapsular cataract formation, acute anterior uveitis, perforation of globe, keratitis, conjunctivitis, corneal ulcer, mydriasis, conjunctival hyperemia, ptosis, loss of accommodation, secondary ocular infection developed, visual acuity defect, field defect, transient ocular discomfort, ocular hypertension, scleral/corneal perforation, foreign body sensation, burning, stinging, irritation, vision blurred/impaired, corneal calcification[Ref]


Frequency not reported: Urticaria, pruritus, rash[Ref]


Frequency not reported: Allergic reaction, anaphylaxis[Ref]


Frequency not reported: Wound healing delayed[Ref]

Nervous system

Frequency not reported: Headache[Ref]


Frequency not reported: Systemic hypercorticoidism[Ref]


Frequency not reported: Dysgeusia[Ref]

More about Inflamase Forte (prednisolone ophthalmic)

Consumer resources

Other brands
Pred Forte, Prednisol, Omnipred, Pred Mild, ... +4 more

Professional resources

Related treatment guides


1. "Product Information. Omnipred (prednisoLONE ophthalmic (prednisolone ophthalmic))." Alcon Laboratories Inc, Fort Worth, TX.

2. "Product Information. Pred Mild (prednisoLONE ophthalmic (prednisolone ophthalmic))." Allergan Inc, Irvine, CA.

3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

4. Cerner Multum, Inc. "Australian Product Information." O 0

5. "Product Information. PrednisoLONE Sodium Phosphate Ophthalmic (prednisoLONE ophthalmic (prednisolone ophthalmic))." Bausch and Lomb, Rochester, NY.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.